Multiple sclerosis and COVID-19

This paper reviews currently available data on the novel coronavirus and clinical features of COVID-19, followed by a detailed section on possible modifications of immunomodulatory therapy in multiple sclerosis patients with COVID-19, based on what we know so far. There are discussed: (i) The COVID-...

Full description

Bibliographic Details
Main Authors: Jan Mares, Hans-Peter Hartung
Format: Article
Language:English
Published: Palacký University Olomouc, Faculty of Medicine and Dentistry 2020-09-01
Series:Biomedical Papers
Subjects:
Online Access:https://biomed.papers.upol.cz/artkey/bio-202003-0001_multiple-sclerosis-and-covid-19.php